C. Chou to Drug Design
This is a "connection" page, showing publications C. Chou has written about Drug Design.
Connection Strength
0.091
-
Design, synthesis, and antitumor evaluation of novel histone deacetylase inhibitors equipped with a phenylsulfonylfuroxan module as a nitric oxide donor. J Med Chem. 2015 May 28; 58(10):4325-38.
Score: 0.028
-
Design and synthesis of a tetrahydroisoquinoline-based hydroxamate derivative (ZYJ-34v), an oral active histone deacetylase inhibitor with potent antitumor activity. Chem Biol Drug Des. 2013 Aug; 82(2):125-30.
Score: 0.025
-
Chemical probes identify a role for histone deacetylase 3 in Friedreich's ataxia gene silencing. Chem Biol. 2009 Sep 25; 16(9):980-9.
Score: 0.019
-
Design and synthesis of novel hybrid benzamide-peptide histone deacetylase inhibitors. Bioorg Med Chem Lett. 2009 Jul 15; 19(14):3928-31.
Score: 0.019